Anais - Instituto de Higiene e Medicina Tropical - Vol.11, 2012

79 / 202

79
ATOUGUIA, J. & KENNED, P. G. (2000) – “Human African
Trypanosomisis”. Em: Davis, L. & Kennedy, P. (eds.), Infectious
Diseases of the Nervous System. Butterworth Heinmann, Oxford.
ATOUGUIA, J. & NELSON, B. D. (2009) – “African
Trypanosomiasis”. Em: SPECTOR, J. M. & GIBSON, T. E. (eds.),
Atlas of Pediatrics in the Tropics and Resource-Limited Settings.
American Academy of Pediatrics, Elk Grove Village / IL.
GOMES, J., LEÃO, C., FERREIRA, F., AFONSO, M. O., SANTOS,
C., JOSENANDO, T., SEIXAS, J., ATOUGUIA, J. & CENTENO-
LIMA, S. (2009) – “Molecular identification of T. brucei s.l.intsetse
flies after long-term permanence in field traps”. J. Infect.Dev.Ctries.,
3: 735-738.
JENNINGS, F. W., ATOUGUIA, J. M. & MURRAY, M. (1993) –
“Topical melarsoprol for trypanosomiasis”. Lancet, 341: 1341-1342.
LANÇA, A. S., DE SOUSA, K., ATOUGUIA, J., PRAZERES, D.M.
F., MONTEIRO, G. A. & SILVA, M. S. (2011) – “Trypanosoma
brucei: Immunisation with plasmidDNA encoding invariant surface
glycoprotein gene is able to induce partial protection in experimental
African trypanosomiasis”. Exper. Parasitol., 127: 18-24.
LUTJE, V., SEIXAS, J. & KENNEDY, A. (2010) – “Chemotherapy
for second-stage Human African trypanosomiasis”. Cochrane
Database of Systematic Reviews 2010, nº 8, Art. CD006201.
ROCHA, G., MARTINS, A., GAMA, G., BRANDAO, F. &
ATOUGUIA, J (2004) – “Possible cases of sexual and congenital
transmission of sleeping sickness”. Lancet, 363 : 247.
SILVA, M. S., PRAZERES, D. M. F., LANÇA, A. S., ATOUGUIA,
J. & MONTEIRO, G. A. (2009) – “Trans-sialidasefromTrypanosoma
brucei as a potential target for DNA vaccine development against
African trypanosomiasis”. Parasitol. Res., 105: 1223-1229.
SIMARRO, P. P., JANNIN, J. & CATTAND, P. (2008) –
“EliminatingHuman African Trypanosomiasis: WhereDoWeStand
and What Comes Next?” PLoS Med., 5 : e55.
“Malária – deficiência em glucose -6-fosfato-desidrogenaseea
terapêutica com primaquina”
ALVES, J., MACHADO, P., SILVA, J., GONÇALVES, N.,
RIBEIRO, L., FAUSTINO, P., DO ROSÁRIO, V. E., MANCO, L.,
GUSMÃO, L., AMORIM, A. & AREZ, A. P. (2010) – “Analysis of
malaria associated genetic traits in Cabo Verde, a melting pot of
European and sub Saharan settlers”. Blood Cells Mol. Dis.,44:62-68.
ALVING, A. S., CARSON, P. E., FLANAGAN, C. L. & ICKES, C.
E. (1956) - “Enzymatic deficiency in primaquine-sensitive
erythrocytes. Science, 124 : 484-485.
DIAS, F. (2012) -Efeito de factores do hospedeiro e parasitáriosna
susceptibilidade à malária e gravidade da doença. Tese de
Doutoramento. Universidade Nova de Lisboa, Portugal.
MATOS, J., DA CRUZ, F. P., CABRITA, E., GUT, J., NOGUEIRA,
F., DO ROSÁRIO, V. E., MOREIRA, R., ROSENTHAL, P. J.,
PRUDÊNCIO, M. & GOMES, P. (2011) – “Novel potent
metallocenes against liver stage malaria”. Antimicrob. Agents
Chemother., 56: 1564-1570.
MIRANDA, J., GONÇALVES, N., PICANÇO, I., DO ROSÁRIO,V.
E., FAUSTINO, P. & AREZ, A. P. (2007) – “Sickle-cell traitandred
cell glucose-6-phosphate dehydrogenase status andmalariamorbidity
in Angola”. Trop. Med. Int. Health, 12(Suppl 1) : 238.
VALE, N., MOREIRA, R. & GOMES, P. (2009a) – “Primaquine
revisited six decades after its discovery”. Eur. J. Med.Chem.,44:937-
953.
VALE, N., NOGUEIRA, F., DO ROSÁRIO, V. E., GOMES, P. &
MOREIRA, R. (2009b) – “Primaquine dipeptide derivatives bearing
an imidazolidin-4-one moiety at the N-terminus as potential
antimalarial prodrugs”. Eur. J. Med. Chem., 44: 2506-2516.
VALE, N., PRUDÊNCIO, M., MARQUES, C. A., COLLINS, M. S.,
GUT, J., NOGUEIRA, F., MATOS, J. P., ROSENTHAL, J.,
CUSHION, M. T., ROSÁRIO, V. DO, MOTA, M. M., MOREIRA,R.
& GOMES, P. (2009c) – “Imidazoquines as antimalarial and
antipneumocystis agentes”. J. Med. Chem., 52: 7800.
WHO (2011) – “World Malaria Report 2011”. [online].
. Acedido em 11 nov 2012.
“Leishmaniose: doença negligenciadadapobrezaeemergenteno
mare nostrum – oito décadas de contributo do IHMT”
ABRANCHES, P., SANTOS-GOMES, G. & CAMPINO, L. (1993)–
“Epidemiology of leishmaniasis in Portugal”. Arch. Inst. Pasteur
Tunis, 70 : 349-355.
CAMPINO, L., SANTOS-GOMES, G., PRATLONG, F., DEDET,J.
P. & ABRANCHES, P. (1994) – “The isolation of Leishmania
donovani MON-18, from an AIDSpatient in Portugal:possibleneedle
transmission”. Parasite, 1: 391-392.
CAMPINO, L. & MAIA, C. (2012) – “The role of reservoirs:canine
leishmaniasis”. Em: PONTE-SUCRE, A., PADRON-NIEVES,M.&
DIAZ, E., Drug Resistance in Leishmania Parasites – Consequences,
Molecular Mechanism and Possible Treatments. Springer Verlag,
Áustria.
CORTES, S., MAURICIO, I., ALMEIDA, A., CRISTOVÃO, J.,
PRATLONG, F., DEDET, J. P. & CAMPINO, L. (2006) –
“Application of kDNA as a molecular marker to analyse Leishmania
infantum diversity in Portugal”. Parasitol. Int., 55: 277-283.
CORTES, S., VAZ, Y., NEVES, R., MAIA, C., CARDOSO, L. &
CAMPINO, L. (2012) – “Risk factors for canine leishmaniasis - A
Portuguese national survey”. Vet Parasitol., 189 : 189-196.
KUHLS, K., CHICHARRO, C., CAÑAVATE, C., CORTES, S.,
CAMPINO, L., HARALAMBOUS, C., SOTERIADOU, K.,
PRATLONG, F., DEDET, J. P., MAURICIO, I., MILES, M.,
SCHAAR, M., OCHSENREITHER, S., RADTKE, O. A. &
SCHÖNIAN, G (2008) – “Differentiation and gene flow among
European populations of Leishmania infantum MON-1”.PLoSNegl.
Trop. Dis., 2: e261.
MAIA, C., GOMES, J., CRISTÓVÃO, J., NUNES, M., MARTINS,
A., REBÊLO, E. & CAMPINO, L. (2010) – “Feline Leishmania
infection in a canine leishmaniasis endemic region, Portugal”. Vet.
Parasitol., 174: 336-340.